CVR 38129562Private limited company (ApS)Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900)StenløseFounded 12 Oct 2016
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Canna Therapeutic ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
3
CVR registry, 2021
Gross profit
-3.4M
DKK, annual report 2020
Result
-3.9M
DKK, annual report 2020
Equity
-9.5M
DKK, annual report 2020
MS INCUBATOR ApSCVR 28656297, 50% to under 66.7% of capital and votes, until 28 May 2024
CBD-International ApSCVR 38752669, 50% to under 66.7% of capital and votes, until 28 May 2024
Steen Plesner Pontoppidanuntil 25 Oct 2021
Equity was negative at 31 Dec 2020: -9.5M DKK. Dandex estimate, computed 10 Nov 2026.
No current owner is registered.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 2865629750% to under 66.7% of capital and votes1 Dec 2018 to 28 May 2024
CVR 2865672650% to under 66.7% of capital and votesnotified 1 Dec 201812 Oct 2016 to 1 Dec 2018
CVR 3875266950% to under 66.7% of capital and votes28 Jun 2017 to 28 May 2024
Canna Therapeutic ApS holds no Danish company now.
Found by searching the CVR owner register (ejerregister) for Canna Therapeutic ApS as owner: Danish companies it holds 5% or more of, and their holdings one level down. Foreign holdings are not in CVR.
CVR 40909672100% of capital and votes1 Nov 2019 to 14 Jun 2022
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Sep 2021, monthly: 3 employees, 2 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 5 | 6 | 6 | 7 | 8 | 9 | 12 | 13 | 13 | 13 | 13 | 14 | 14 | 14 | 13 | 11 | 12 | 13 | 12 | 11 | 9 | 9 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 4 | 4 | 3 |
| FTE | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 5 | 5 | 6 | 6 | 7 | 9 | 10 | 11 | 11 | 11 | 12 | 13 | 12 | 12 | 10 | 11 | 11 | 10 | 10 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 3 | 3 | 2 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly Nov 2016 to Sep 2021.
CVR changed its monthly method in Oct 2019, so a step at that month need not be real.
Latest Sep 2021, published 19 Nov 2022. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Gross profit | Not reported | Not reported | -3,744 | -3,449 |
| Operating profit | -1,607 | -1,254 | -4,407 | -4,892 |
| Result for the year | -1,254 | -981 | -4,348 | -3,875 |
| Equity | -254 | -1,235 | -5,584 | -9,459 |
| Total assets | 989 | 765 | 35,934 | 43,572 |
| Employees (average) | 2 | 2 | 8 | 8 |
| Credit metrics (Dandex calculations) | ||||
| EBITDA | -1,433 | -1,121 | -4,262 | -4,376 |
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | 0% | 300% | 300% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -30note 2 | -7note 2 | -6note 2 | -790note 2 |
| Interest coverage (rentedækning) | -1,338.9x | -474.5x | -3.8x | -75.2x |
| Adjusted equity ratio (justeret soliditetsgrad) | -25.7%note 3 | -161.5%note 3 | -181.2%note 4 | -192%note 4 |
| Capex (investeringer i anlægsaktiver) | Not reportednote 5 | 2note 6 | 24,370note 6 | 5,492note 6 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | 326note 2 | -7note 2 | -6note 2 | -790note 2 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. Not every period is a full year: 2017 covers 15 months (12 Oct 2016 to 31 Dec 2017). Changes against it compare periods of different length.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Each registered value from the day it took effect, newest first.
From CVR, read 10 Nov 2026. Text such as the signing rule and purpose is shown as registered.
6 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Konkursbehandlingen afsluttet 28.05.2024, virksomheden opløst
Konkursdekret afsagt 25.10.2021 af Skifteretten i Hillerød
Direktion:
Fratrådte:
Steen Plesner Pontoppidan, (adm. dir), den 25.10.2021.
Revision:
Revision:
Fratrådte:
Døssing & Partnere Revisionsinteressentskab, den 06.07.2018.
Ny adresse: Gymnasievej 5, 3660 Stenløse
Ny kommune: Egedal
Ny adresse: Fruebjergvej 3, 2100 København Ø
Ny kommune: København
Stiftelsesdato: 12.10.2016.
Virkningsdato: 12.10.2016.
Seneste vedtægtsdato: 12.10.2016.
Kapital:
kr. 500.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 250.000,00 til kurs 200,00, fuldt indbetalt.Indbetalt i værdier kr. 250.000,00 til kurs 200,00, fuldt indbetalt.
Stiftere:
CVR-NR. 28656726 MSVISION ApS, c/o Steen Pontoppidan, Sandholmvej 5, 3450 Allerød, den 12.10.2016, CVR-NR. 36699108 CBD-Danmark Holding ApS, Kappelevvej 26, 2670 Greve, den 12.10.2016.
Direktion:
Steen Plesner Pontoppidan (adm. dir), den 12.10.2016.
Selskabet tegnes af den administrerende direktør eller af den samlede direktion.
Revision:
CVR-NR. 54879911 Døssing & Partnere Revisionsinteressentskab, c/o TROLLESMINDE KONTORPARK, Roskildevej 12A, 3400 Hillerød, den 12.10.2016.
Første regnskabsår:
12.10.2016 - 31.12.2017.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at forske i og udvikle lægemidler baseret på naturstoffer og dermed beslægtet virksomhed efter direktionens skøn
1 registered in CVR.
P-number 1021864885Gymnasievej 5, 3660 Stenløse
